Suppr超能文献

别构调节和蛋白激酶抑制。

Allosteric regulation and inhibition of protein kinases.

机构信息

Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, U.S.A.

出版信息

Biochem Soc Trans. 2023 Feb 27;51(1):373-385. doi: 10.1042/BST20220940.

Abstract

The human genome encodes more than 500 different protein kinases: signaling enzymes with tightly regulated activity. Enzymatic activity within the conserved kinase domain is influenced by numerous regulatory inputs including the binding of regulatory domains, substrates, and the effect of post-translational modifications such as autophosphorylation. Integration of these diverse inputs occurs via allosteric sites that relate signals via networks of amino acid residues to the active site and ensures controlled phosphorylation of kinase substrates. Here, we review mechanisms of allosteric regulation of protein kinases and recent advances in the field.

摘要

人类基因组编码了超过 500 种不同的蛋白激酶:具有严格调控活性的信号酶。在保守的激酶结构域内,酶的活性受到许多调节输入的影响,包括调节结构域、底物的结合以及翻译后修饰(如自身磷酸化)的影响。这些不同的输入通过别构位点进行整合,通过氨基酸残基网络将信号传递到活性位点,并确保激酶底物的受控磷酸化。在这里,我们回顾了蛋白激酶别构调节的机制以及该领域的最新进展。

相似文献

1
Allosteric regulation and inhibition of protein kinases.别构调节和蛋白激酶抑制。
Biochem Soc Trans. 2023 Feb 27;51(1):373-385. doi: 10.1042/BST20220940.
2
Networks for the allosteric control of protein kinases.用于蛋白激酶变构控制的网络
Curr Opin Struct Biol. 2006 Dec;16(6):686-92. doi: 10.1016/j.sbi.2006.10.011. Epub 2006 Nov 7.
6
Hierarchical Organization Endows the Kinase Domain with Regulatory Plasticity.层次组织赋予激酶结构域以调节可塑性。
Cell Syst. 2018 Oct 24;7(4):371-383.e4. doi: 10.1016/j.cels.2018.08.008. Epub 2018 Sep 19.
8
Engineering allosteric regulation in protein kinases.工程化蛋白激酶的别构调控。
Sci Signal. 2018 Nov 6;11(555):eaar3250. doi: 10.1126/scisignal.aar3250.

引用本文的文献

1
How residence time works in allosteric drugs.变构药物中的驻留时间是如何起作用的。
Curr Opin Struct Biol. 2025 Aug 29;94:103149. doi: 10.1016/j.sbi.2025.103149.
3
Drug resistance and tumor heterogeneity: cells and ensembles.耐药性与肿瘤异质性:细胞与细胞群体
Biophys Rev. 2025 May 31;17(3):759-779. doi: 10.1007/s12551-025-01320-y. eCollection 2025 Jun.

本文引用的文献

4
Oral surveillance and JAK inhibitor safety: the theory of relativity.口腔监测与 JAK 抑制剂安全性:相对论。
Nat Rev Rheumatol. 2022 May;18(5):301-304. doi: 10.1038/s41584-022-00767-7. Epub 2022 Mar 22.
6
Conformational switches that control the TEC kinase - PLCγ signaling axis.控制TEC激酶-PLCγ信号轴的构象开关。
J Struct Biol X. 2022 Jan 22;6:100061. doi: 10.1016/j.yjsbx.2022.100061. eCollection 2022.
7
Overcoming therapy resistance in EGFR-mutant lung cancer.克服 EGFR 突变型肺癌的治疗抵抗。
Nat Cancer. 2021 Apr;2(4):377-391. doi: 10.1038/s43018-021-00195-8. Epub 2021 Apr 15.
9
GCN2 kinase activation by ATP-competitive kinase inhibitors.GCN2 激酶被 ATP 竞争型激酶抑制剂激活。
Nat Chem Biol. 2022 Feb;18(2):207-215. doi: 10.1038/s41589-021-00947-8. Epub 2021 Dec 23.
10
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.使用CDK2/4/6抑制剂扩大对肿瘤细胞周期的控制。
Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验